Wednesday - December 25, 2024

Universal Anti-Cd22 Chimeric Antigen Receptor Engineered Immune Cells

2024-11-05

ALEXANDRIA, Virginia, Nov. 5 -- CELLECTIS SA, Paris, France has been assigned a patent (No. US 12133867 B2, initially filed Dec. 21, 2023) developed by three inventors Julianne Smith, New York, New York; Phillippe Duchateau, Draveil, France; and Murielle Derrien, Paris, France, for "Universal anti-CD22 chimeric antigen receptor engineered immune cells." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Universal Anti-Cd22 Chimeric Antigen Receptor Engineered Immune Cells

Information Request Form

Copyright Targeted News Service 2024